• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL NAVITOR TRANSCATHETER AORTIC VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL NAVITOR TRANSCATHETER AORTIC VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number NVTR-27
Device Problems Migration or Expulsion of Device (1395); Improper or Incorrect Procedure or Method (2017)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/14/2023
Event Type  Injury  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that on (b)(6) 2023, a 27mm navitor was selected for an implanted.The starting implant depth was 3mm.The sizing of the annular dimensions was: 18.7 x 27.8 (min x max), perimeter derived 23.8mm.During the procedure, due to heavy calcification of native valve and hypertrophic ventricle, the device migrated and was snared into ascending aorta.The physician aware of the ifu warning against snaring the valve.No hypertensive spike or pulmonary hypertensive episode was detected when the device migrated.A non-abbott device was selected and implanted successfully.The patient was reported to be in stable condition.No additional information was provided.
 
Manufacturer Narrative
An event of device migration was reported.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed, and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.Information from the field also indicated that due to heavy calcification of native valve and hypertrophic ventricle the device migrated.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.Please note that per the instructions for use."post-implantation precautions: once the valve is fully deployed, repositioning and retrieval of the valve is not possible.Attempted retrieval (e.G., use of a guidewire, snare, or forceps) may cause aortic root, coronary artery, and/or myocardial damage.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NAVITOR TRANSCATHETER AORTIC VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key16526442
MDR Text Key311136313
Report Number2135147-2023-01136
Device Sequence Number1
Product Code NPT
UDI-Device Identifier05415067031594
UDI-Public05415067031594
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
P190023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberNVTR-27
Device Catalogue NumberNVTR-27
Device Lot Number8540680
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/14/2023
Initial Date FDA Received03/10/2023
Supplement Dates Manufacturer Received04/21/2023
Supplement Dates FDA Received05/11/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/08/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-